Physician profile
William E Baucom
NPI 1952353054
$267.06
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $112 · 2022: $53.33 · 2023: $42.21 · 2024: $59.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $101.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $47.04 | 2021 | |
| Abbvie INC. | $40.11 | 2021 | |
| Novartis Pharmaceuticals Corporation | $37.70 | 2022 | |
| Ethicon INC. | $36.63 | 2024 | Monarch Platform |
| Pfizer INC. | $24.98 | 2021 | |
| Novo Nordisk INC | $22.76 | 2024 | Rybelsus, Ozempic |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.18 | 2023 | Trulance, Xifaxan |
| Lilly USA, LLC | $15.63 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.45 | 2023 | Breztri |
| Endogastric Solutions, INC | $9.58 | 2023 | Esophyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Baucom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.